Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Rozenblit · SciRah

Researcher profile · Semantic Scholar

M. Rozenblit

Share profile

M. Rozenblit — researcher profile on SciRah

h-index: 19
Works: 86
Citations: 1,432

Most-cited papers

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response.
N. Dhingra, A. Shemer, J. C. Corrêa da Rosa, M. Rozenblit +11 more
2014Journal of Allergy and Clinical Immunology266 citations
Semantic Scholar
Cyclosporine A in Atopic Dermatitis Modulates activated inflammatory pathways and reverses epidermal pathology
S. Khattri, A. Shemer, M. Rozenblit, N. Dhingra +12 more
2014Journal of Allergy and Clinical Immunology169 citations Open access
Semantic Scholar
Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers
M. Rozenblit, Richard Huang, N. Danziger, P. Hegde +6 more
2020Journal for ImmunoTherapy of Cancer116 citations Open access
Semantic Scholar
Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
J. C. Corrêa da Rosa, Dana Malajian, A. Shemer, M. Rozenblit +12 more
2015Journal of Allergy and Clinical Immunology76 citations Open access
Semantic Scholar
Retrospective study of the efficacy of narrowband UVB and acitretin
P. Spuls, M. Rozenblit, M. Lebwohl
2003Journal of dermatological treatment (Print)69 citations
Semantic Scholar
New biologics for psoriasis and psoriatic arthritis
M. Rozenblit, M. Lebwohl
2009Dermatologic Therapy65 citations
Semantic Scholar
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
M. Lambertini, E. Blondeaux, E. Agostinetto, A. Hamy +50 more
2023Journal of the American Medical Association (JAMA)64 citations Open access
Semantic Scholar
Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla.
Gang Wang, C. Drake, M. Rozenblit, P. Zhou +6 more
2006Brain Research59 citations
Semantic Scholar
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomised I-SPY2.2 phase 2 trial
R. Shatsky, M. Trivedi, C. Yau, Rita Nanda +56 more
2024Nature Medicine55 citations Open access
Semantic Scholar
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.
E. Blondeaux, A. Sonnenblick, E. Agostinetto, R. Bas +45 more
2025The Lancet Oncology50 citations
Semantic Scholar
Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy
M. Rozenblit, S. Mun, P. Soulos, K. Adelson +2 more
2021Breast Cancer Research41 citations Open access
Semantic Scholar
Predictive markers of response to neoadjuvant durvalumab with nab-paclitaxel and dose dense doxorubicin/cyclophosphamide in basal-like triple negative breast cancer
K. Blenman, M. Marczyk, T. Karn, T. Qing +16 more
2022Clinical Cancer Research34 citations Open access
Semantic Scholar
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
T. Qing, T. Karn, M. Rozenblit, J. Foldi +7 more
2022npj Breast Cancer32 citations Open access
Semantic Scholar
Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers.
L. Arecco, M. Bruzzone, R. Bas, H. J. Kim +42 more
2024Annals of Oncology31 citations Open access
Semantic Scholar
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status
M. Lambertini, E. Blondeaux, L. Tomasello, E. Agostinetto +35 more
2025Journal of Clinical Oncology28 citations Open access
Semantic Scholar
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod
M. Rozenblit, W. Hendrickx, A. Heguy, L. Chiriboga +8 more
2019Scientific Reports28 citations Open access
Semantic Scholar
More than bad luck: Cancer and aging are linked to replication-driven changes to the epigenome
Christopher Minteer, Kyra L. Thrush, John T. González, Peter Niimi +12 more
2023Science Advances24 citations Open access
Semantic Scholar
Residual genomic profile after cyclosporine may offer insights into atopic dermatitis reoccurrence
M. Rozenblit, M. Suárez-Fariñas, A. Shemer, S. Khattri +7 more
2014Journal of Allergy and Clinical Immunology24 citations Open access
Semantic Scholar
Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy
J. Foldi, M. Rozenblit, T. Park, C. Knowlton +3 more
2021Current Treatment Options in Oncology20 citations
Semantic Scholar
Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study
F. Schettini, E. Blondeaux, C. Molinelli, R. Bas +41 more
2024Cancer19 citations Open access
Semantic Scholar
Evidence of accelerated epigenetic aging of breast tissues in patients with breast cancer is driven by CpGs associated with polycomb-related genes
M. Rozenblit, E. Hofstatter, Zuyun Liu, T. O'Meara +5 more
2021Clinical Epigenetics18 citations Open access
Semantic Scholar
Datopotamab-deruxtecan in early stage breast cancer: the I-SPY2.2 sequential multiple assignment randomized phase 2 trial
Katia Khoury, J. Meisel, C. Yau, H. Rugo +53 more
2024Nature Medicine17 citations Open access
Semantic Scholar
Accelerated Aging in Cancer and Cancer Treatment: Current Status of Biomarkers
Soniya Abraham, Jay Parekh, Seohyuk Lee, H. Afrin +7 more
2025Cancer Medicine13 citations Open access
Semantic Scholar
Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years
D. McFarland, Jessica Naikan, M. Rozenblit, J. Mandeli +2 more
2016Journal of Oncology13 citations Open access
Semantic Scholar
De Novo Oligometastatic Breast Cancer.
L. Pusztai, M. Rozenblit, P. Dubsky, T. Bachelot +7 more
2023Journal of Clinical Oncology11 citations
Semantic Scholar
Prognostic Value of Circulating Tumor DNA in HR+/HER2− Stage I–III Breast Cancer: A Systematic Review
I. Ajjawi, M. Rozenblit, A. Ríos-Hoyo, M. Lustberg
2025Cancers8 citations
Semantic Scholar
PD-L1 protein expression in relation to recurrence score values in early-stage ER + breast cancer
M. Rozenblit, K. Blenman, M. Harigopal, Emily S. Reisenbichler +10 more
2022Breast Cancer Research and Treatment8 citations
Semantic Scholar
Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis
S. Maryles, M. Rozenblit, M. Lebwohl
2003Journal of dermatological treatment (Print)8 citations
Semantic Scholar
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology
E. Agostinetto, M. Bruzzone, A. Hamy, H. J. Kim +38 more
2024ESMO Open7 citations Open access
Semantic Scholar
Genomic landscape and homologous recombination repair deficiency signature in stage I-III and de novo stage IV primary breast cancers
J. Jeon, Kuei-Ting Chen, R. Madison, A. Schrock +5 more
2025The Oncologist5 citations Open access
Semantic Scholar
Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence-Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials.
Guan-Nan Gong, Jessica Liu, Sameer Pandya, C. Taborda +24 more
2026JCO Clinical Cancer Informatics4 citations
Semantic Scholar
Genomic alterations in normal breast tissues preceding breast cancer diagnosis
J. Dai, M. Rozenblit, Xiao-Yue Li, N. Shan +4 more
2025Breast Cancer Research4 citations Open access
Semantic Scholar
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay
Hao-Kuen Lin, Thuy Can, Adriana M. Kahn, Cynthia A. Flannery +6 more
2023The Oncologist4 citations Open access
Semantic Scholar
Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study
Deanna Blansky, Norin Ansari, Lucy Gao, E. Sokol +9 more
2023Breast Cancer Research and Treatment4 citations
Semantic Scholar
Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer
M. Rozenblit, Maryam B. Lustberg
2021Annals of Translational Medicine4 citations Open access
Semantic Scholar
Cancer relevance of human genes
T. Qing, Hussein Mohsen, Vincent L. Cannataro, M. Marczyk +7 more
2021bioRxiv4 citations Open access
Semantic Scholar
Abstract P1-11-16: Impact of ribociclib dose reduction on efficacy in patients with hormone receptor– "positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) early breast cancer (EBC) in NATALEE”
E. Hamilton, T. Decker, H. Rugo, M. Abad +12 more
2025Clinical Cancer Research3 citations
Semantic Scholar
Abstract RF3-01: TBCRC 056: A Phase II Study of Neoadjuvant Niraparib with Dostarlimab for Patients with BRCA- or PALB2-mutated Breast Cancer: Results From the ER+/HER2- Cohort
E. Mayer, N. Graham, R. Leon-Ferre, M. Rozenblit +14 more
2025Clinical Cancer Research3 citations
Semantic Scholar
HER2‐Targeted Antibody‐Drug Conjugate Toxicities in Breast Cancer
Seohyuk Lee, A. Kahn, M. Rozenblit, M. George +2 more
2025Cancer Medicine3 citations
Semantic Scholar
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study
M. Lambertini, E. Blondeaux, E. Agostinetto, A. Hamy +50 more
2024Obstetrical & Gynecological Survey3 citations Open access
Semantic Scholar
The correlation of ESR1 genetic aberrations with estrogen receptor and progesterone receptor status in metastatic and primary estrogen receptor-positive breast carcinomas.
Jennifer Moreira-Dinzey, Haiying Zhan, M. Rozenblit, Uma Krishnamurti +3 more
2023Human Pathology3 citations
Semantic Scholar
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.
C. Becherini, E. Blondeaux, V. Delucchi, L. Visani +41 more
2026Radiotherapy and Oncology2 citations Open access
Semantic Scholar
Rates of pathologic complete response (pCR)after neoadjuvant datopotamab deruxtecan (Dato): Results from the I-SPY2.2 trial.
J. Meisel, Katia Khoury, A. Chien, A. Wallace +15 more
2024Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Current management practices of de novo oligometastatic breast cancer: Real-world data from a physician survey.
Nicole Odzer, L. Pusztai, M. Rozenblit
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract PR009: Revisiting the bad luck hypothesis: Cancer risk and aging are linked to replication-driven changes to the epigenome
Christopher Minteer, Kyra L. Thrush, Peter Niimi, J. Rozowsky +9 more
2023Cancer Research2 citations
Semantic Scholar
Abstract RF5-02: Tbcrc 056: a phase 2 study of neoadjuvant niraparib with dostarlimab for patients with BRCA- or PALB2-mutated breast cancer: results from the TNBC cohorts
E. Mayer, N. Graham, R. Leon-Ferre, M. Rozenblit +15 more
2026Clinical Cancer Research1 citations
Semantic Scholar
Mutational landscape of normal breast tissues adjacent to invasive breast cancer
A. Suwalska, M. Rozenblit, M. Harigopal, J. Dai +4 more
2026Cell Reports Medicine1 citations
Semantic Scholar
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results
K. Fanucci, M. Rozenblit, J. Quintanilha, R. Graf +11 more
2026npj Breast Cancer1 citations Open access
Semantic Scholar
Abstract P4-02-04: Development of ASSESS, a breast cancer decision support tool using SEER data and treatment benefit estimates from randomized adjuvant therapy trials
M. Marczyk, Joanna Tobiasz, M. Rozenblit, R. Volk +3 more
2025Clinical Cancer Research1 citations
Semantic Scholar
Surgeon Attitudes on the Management of de novo Oligometastatic Breast Cancer
Malia Brennan, J. Plichta, M. Rozenblit, M. Flanagan
2025Annals of Surgical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Pusztai×12
Invite
L. Pusztai — researcher profile on SciRah
M. Lambertini×8
Invite
M. Lambertini — researcher profile on SciRah
E. Blondeaux×8
Invite
E. Blondeaux — researcher profile on SciRah
E. Agostinetto×8
Invite
E. Agostinetto — researcher profile on SciRah

C. Rousset-Jablonski

×8

Invite

C. Rousset-Jablonski — researcher profile on SciRah

Invite

W. Cui — researcher profile on SciRah

Invite

M. Dieci — researcher profile on SciRah

Invite

A. Matikas — researcher profile on SciRah

L. De Marchis×8

Invite

L. De Marchis — researcher profile on SciRah

Invite

K. Pogoda — researcher profile on SciRah

Invite

T. Renaud — researcher profile on SciRah

S. Paluch-Shimon×7

Invite

S. Paluch-Shimon — researcher profile on SciRah